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There are strong a priori reasons for considering parental smoking behaviour as a risk factor for childhood cancer but case – control
studies have found relative risks of mostly only just above one. To investigate this further, self-reported smoking habits in parents of
3838 children with cancer and 7629 control children included in the United Kingdom Childhood Cancer Study (UKCCS) were
analysed. Separate analyses were performed for four major groups (leukaemia, lymphoma, central nervous system tumours and other
solid tumours) and more detailed diagnostic subgroups by logistic regression. In the four major groups, after adjustment for parental
age and deprivation there were nonsignificant trends of increasing risk with number of cigarettes smoked for paternal preconception
smoking and nonsignificant trends of decreasing risk for maternal preconception smoking (all P-values for trend 40.05). Among the
diagnostic subgroups, a statistically significant increased risk of developing hepatoblastoma was found in children whose mothers
smoked preconceptionally (OR¼2.68, P¼0.02) and strongest (relative to neither parent smoking) for both parents smoking
(OR¼4.74, P¼0.003). This could be a chance result arising from multiple subgroup analysis. Statistically significant negative trends
were found for maternal smoking during pregnancy for all diagnoses together (Po0.001) and for most individual groups, but there
was evidence of under-reporting of smoking by case mothers. In conclusion, the UKCCS does not provide significant evidence that
parental smoking is a risk factor for any of the major groups of childhood cancers.
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There are strong a priori reasons for considering parental smoking
behaviour as a risk factor for childhood cancer. Many proven
carcinogens are present in tobacco and tobacco smoke (Hecht,
1999; Hoffmann and Hoffmann, 1997). Tobacco-related com-
pounds have also been detected in human placenta, fetal blood,
urine of offspring and in breast milk of smoking mothers (Perlman
and Dannenberg, 1942; Everson et al, 1986, 1988; Woodward et al,
1986; Hansen et al, 1992; Myers et al, 1996; Pinorini-Godly and
Myers, 1996; Arnould et al, 1997; Daube et al, 1997).
Previous case–control studies have tended to show weak
associations between maternal cigarette smoking during preg-
nancy and childhood cancers (IARC, 1986; Severson et al, 1993;
Tredaniel et al, 1994; Sorahan et al, 1995, 1997a, b, 2001; Klebanoff
et al, 1996; Shu et al, 1996). There is somewhat stronger and more
consistent evidence for a paternal preconceptional effect, although
relative risks in most case–control studies are only just above one
(Severson et al, 1993; Shu et al, 1996; Ji et al, 1997; Sorahan et al,
1997b; 2001). This effect has been attributed to germ-cell
mutations during spermatogenesis caused by tobacco products
(Wyrobeck, 1993; Wyrobek and Adler, 1996; Woodall and
Ames, 1997). Relevant studies are reviewed by Thornton and Lee
(1998).
The United Kingdom Childhood Cancer Study (UKCCS) is a
nationwide population-based case–control study of possible
aetiological factors in childhood cancer. We have examined the
possible effect of paternal and maternal cigarette smoking in the
development of childhood cancers by analysing self-reported
parental smoking habits in relation to such cancers at a
preconceptional time period and maternal smoking during
pregnancy. Information on paternal smoking during pregnancy
was not collected as maternal passive smoking during pregnancy
was not considered important when the study was designed.
MATERIALS AND METHODS
The UKCCS study design, case and control selection, and data
collection procedures have already been published in detail
(McKinney et al, 1995; UK Childhood Cancer Study Investigators,
2000). A summary is provided here.
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The study sought to interview the parents of children, resident in
England, Scotland and Wales, who were diagnosed with a
confirmed malignancy or any central nervous system (CNS)
tumour under the age of 15 years between 1991–1994 in Scotland
and 1992–1994 in England and Wales. Case accrual continued in
England and Wales for non-Hodgkin’s lymphoma and leukaemias
during 1995 and leukaemias alone during 1996. A total of 10 study
regions were defined. Cases were usually ascertained from regional
paediatric oncology units. Completeness of ascertainment was
checked by cross-reference to regional and national cancer
registries. Leukaemia diagnoses and subclassification were based
on all available data including data from national clinical trials. For
solid tumours, consensus diagnoses were made by panels of
pathologists with special interests in specific types of tumours after
histopathological review. All diagnoses were coded according to
International Classification of Diseases for Oncology (2nd ed.)
(Percy et al, 1990) and regrouped into Birch and Kelsey diagnostic
subcategories (UKCCS Investigators, 2000), available at http://
www.biomed2.man.ac.uk/crcpfcrg/crukpfcrg/pfcrg.htm.
Control selection
For each case child, similar data were sought for two control
children matched for sex, date of birth and geographical area of
residence at diagnosis and randomly selected from Family Health
Services Authorities (FHSA) lists in England and Wales and Health
Boards in Scotland. Control parents were contacted following
permission from their general practitioners (GP). The parents of
3838 case children and 7629 control children were interviewed,
representing participation rates of 87 and 64%, respectively.
Parental smoking behaviour
Evaluable parental smoking data obtained from face-to-face
structured interviews with parents were available on 3585 case
fathers, 6987 control fathers, 3814 case mothers and 7581 control
mothers. We developed software to derive the preconception
smoking variable from the social habits section of the ques-
tionnaire on the basis of the starting and stopping dates of
smoking, specific questions relating to smoking 1 year before birth
of the index child and at other time points and the birth date of the
index child. Parental smoking status was categorised as: (a)
lifelong nonsmokers; (b) ex-smokers, who stopped smoking more
than 1 year before the birth of the index child; and (c) current
smokers, who smoked cigarettes during the year before the birth of
the index child. When smoking status was unknown (8% of
parents overall) because of missing information or contradictory
information, these were excluded from statistical analyses to avoid
bias of odds ratios (ORs) because of possible misclassification of
smoking status (Lee, 1998; Infante-Rivard and Jacques, 2000). A
smoking variable defining numbers of cigarettes smoked per day
during specific periods of pregnancy was derived from the
interview data. Maternal smoking during the second trimester of
pregnancy is reported since fetal organs have by then developed
and have begun to function. It was considered that fetal organ
exposure to products of tobacco smoking in this period might
replicate the tissue-specific effects suggested by animal studies.
Statistical methods
As in previous UKCCS reports (UKCCS Investigators, 1999; Beral
et al, 2001), case and control data relating to cigarette consump-
tion were compared by means of unconditional logistic regression
(Breslow and Day, 1980) using Stata, version 6, program
(StataCorp, 1999). The original matching variables were accounted
for by adjustment, with all analyses being routinely adjusted for
child’s age at diagnosis in single years (0–14) treated as a
continuous variable, sex and UKCCS region (Beral et al, 2001). All
controls were used as the comparison group for each diagnostic
group. Since it is known that spontaneous mutation rates can
increase with age, especially in males (Penrose, 1955, 1957; Vogel
and Rathenberg, 1975), adjustments were made for parental ages at
the birth of the child (in single years) and for deprivation score.
The latter is a small-area seven-level index based on car ownership,
overcrowding and unemployment. Individual scores were obtained
by linking to the 1991 census of Great Britain via the postcodes of
their residence at diagnosis/pseudodiagnosis of the index children
(UKCCS Investigators, 2000).
Analyses were performed with respect to paternal and maternal
preconception smoking, and maternal smoking in pregnancy,
initially by the following broad diagnostic groups: all cancers,
leukaemia, lymphoma, central nervous system tumours (CNS) and
other solid tumours. Possible dose–response relations between
smoking and childhood cancer were examined using three
smoking categories of 0, 1–19, and 20 or more cigarettes smoked
per day (cpd). Relative risks were estimated for light/moderate
(1–19cpd) and heavy (20+cpd) smokers relative to nonsmokers.
ORs were computed and shown relative to a baseline risk of unity
for the nonsmokers together with two-sided P-values and 95%
confidence intervals (CI). The trend of risk by amount smoked was
examined by coding the three smoking groups to 1, 2 and 3,
respectively, and treating as a continuous variable (Sorahan et al,
1997a, b).
Work on single gene cancer predisposition syndromes, on
specific somatic mutations in human cancers and on laboratory
animals suggests that any mutagenic/carcinogenic effects of
tobacco smoke would be tissue specific and/or organ specific
(Correa et al, 1990; Beebe et al, 1993; Hecht, 1998; Birch, 1999;
Hollstein et al, 1999). Therefore, separate analyses were performed
for Birch and Kelsey diagnostic subgroups, which group biologi-
cally similar tumours together (UKCCS Investigators, 2000). In
those groups showing a statistically significantly elevated OR, the
relation was explored in more detail as follows: father’s smoking in
the absence of mother’s smoking, mother’s smoking in the absence
of father’s smoking, and both father and mother smoking were
compared with neither smoking for data on parental preconcep-
tion smoking.
If parental smoking is a risk factor for childhood cancer,
germline mutations caused by a preconceptional exposure might
lead to earlier age of cancer onset in the child, whereas a
transplacental exposure may be associated with later age of onset.
To investigate this possibility, analyses were carried out for
children, under and above the median age at diagnosis,
respectively, in diagnostic groups with elevated ORs.
RESULTS
Table 1 shows details of subjects and their biological parents. In
total 56% are boys and about 50% are under 5 years old at
diagnosis. Case and control children have similar distributions by
sex and age at diagnosis. The mother’s mean age at birth of the
index child is 27 years and the father’s is 30 years. Case parents are
slightly younger than control parents. For all cancers, ORs for the
child’s age at diagnosis and sex are close to 1 due to matching (all
ORs¼1.0, all P-valuesX0.5). Nevertheless, these matching vari-
ables were included in the model to avoid a biased estimate of the
parental smoking effect (Clayton and Hills, 1993). There is a
significant negative trend for maternal age at the birth of the index
child (P-value for trend o0.001), but a nonsignificant positive
trend for paternal age (P-value for trend¼0.4). There is a
significant positive trend for deprivation (P-value for trend
o0.05).
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main diagnostic groups. Overall, there was a nonsignificant trend
of increasing risks with amount smoked after adjustment for
parental age and deprivation. Although some statistically sig-
nificant ORs were shown among fathers with 1–19cpd, adjustment
for parental age and deprivation removed these.
For maternal preconception smoking, Table 3 shows a
statistically significant decreased OR of 0.86 among heavy smokers
after adjustment (P¼0.03), also seen for other solid tumours
(OR¼0.75, P¼0.02).
For all diagnoses considered together, the OR for paternal
preconceptional smoking in cases below, or at or above, the
median age was 1.03 (P¼0.7) and 1.05 (P¼0.4), respectively. For
maternal preconceptional smoking, the corresponding ORs were
0.91 (P¼0.2) and 1.00 (P¼1.0). Therefore, there was no evidence
of a general tendency for increased risk at younger ages that may
have been associated with germline mutations in relevant genes.
Table 4 shows, for maternal smoking during pregnancy,
significant monotonic decreasing trends in risk with amount
smoked for all cancers, leukaemia, lymphoma, CNS tumours and
other solid tumours (Po0.001, P¼0.03, P¼0.01 and P¼0.03
respectively), with ORs statistically significantly below 1 among
heavy smokers.
Table 5 shows ORs by the Birch–Kelsey diagnostic subgroup.
For paternal preconception smoking, most subgroups showed ORs
close to unity, but choroid plexus tumours and hepatoblastoma
showed statistically nonsignificant elevated ORs (OR¼2.1 and 2.2)
after adjustment for parental age and deprivation. For maternal
preconception smoking, only hepatoblastoma showed a signifi-
cantly elevated OR (OR¼2.68, P¼0.02) after adjustment for
parental age and deprivation. For the other subgroups, ORs were
close to unity. For maternal smoking during pregnancy, ORs in
most diagnostic subgroups were below unity and not statistically
significant, but for primitive neuroectodermal tumours the OR was
0.55 (P¼0.01).
For hepatoblastoma, Table 6 shows results for parental smoking
by age, number of cpd, and number of parents smoking. For
maternal preconception smoking, there was a statistically sig-
nificantly elevated OR of 12 for children older than the median age
at diagnosis after adjustment for parental age and deprivation
(P¼0.002) and a positive trend with number of cigarettes smoked
per day of borderline statistical significance (P¼0.06). The
strongest effect is seen for both parents smoking preconceptionally
(OR¼4.74, P¼0.003).
DISCUSSION
The UKCCS does not provide evidence that parental preconception
smoking is a risk factor for childhood cancers in general.
Statistically significant point estimates of risks just above unity
can be accounted for by the potential confounders. There are no
statistically significant trends with increasing number of cigarettes
smoked. Failure to replicate the findings of two nationwide and
multiregional case–control studies in the UK (Sorahan et al, 1995,
1997a, b, 2001), which found significant associations with paternal
preconception smoking, may be due, in part, to a higher smoking
prevalence, and a larger proportion of heavy smokers in those
earlier studies. More importantly, perhaps, the present study is
more likely to be subject to reporting bias because of increased
public awareness of adverse effects of smoking and blinding
parents with respect to the study hypothesis regarding smoking
was impracticable.
It is noteworthy that the analyses of data on children dying of
cancer between 1953 and 1976, which showed significant trends
with paternal smoking, showed no significant association with
maternal smoking after allowing for paternal smoking (Sorahan
et al, 1995, 1997a, b). In these earlier studies the reliability of self-
reported smoking in mothers was suggested by analyses of birth
weights, which showed lower birth weights in children of smoking
mothers. These data were collected at a time when there was little
pressure on mothers to stop smoking during pregnancy and
therefore less liability to bias.
Table 1 Characteristics of study subjects and their biological parents
Maternal data available Paternal data available
Cases Controls Cases Controls
n % n % n % n %
Child
Sex
Boys 2139 56.1 4259 56.2 2020 56.3 3913 56.0
Girls 1675 43.9 3322 43.8 1565 43.7 3074 44.0
Age at diagnosis (years)
0 315 8.3 632 8.3 307 8.6 604 8.6
1–4 1596 41.8 3175 41.9 1515 42.3 2943 42.1
5–9 1042 27.3 2057 27.1 971 27.1 1880 26.9
10–14 861 22.6 1717 22.6 792 22.1 1560 22.3
Parent
Age at birth of the child (years)
Mean (s.d.) 27.5 (5.2) 27.9 (5.2) 30.4 (6.1) 30.7 (6.0)
Median 27.3 27.7 29.8 30.1
Parental cigarette smoking at conception
No 2344 61.5 4674 61.7 1964 54.8 3909 55.9
Yes 1193 31.3 2375 31.3 1348 37.6 2463 35.3
Unknown 277 7.3 532 7.0 273 7.6 615 8.8
Parental cigarette smoking in pregnancy
No 2958 77.6 5743 75.8 FF F F
Yes 855 22.4 1834 24.2 FF F F
Unknown 1 0.0 4 0.0 FF F F
Parental smoking and childhood cancer
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negative trends for maternal smoking during pregnancy for most
diagnostic groups. A protective effect for these types does not seem
biologically plausible here, and it is more likely that these trends
reflect an underestimation of the amount smoked by case mothers
during the index pregnancy.
Birth weights of index children reported by mothers at interview
were analysed in cases and controls for trend with reported
numbers of cigarettes smoked during the second trimester of
pregnancy. In controls, there was a trend of monotonic decrease in
birth weights with numbers of cigarettes smoked (differences in
mean birth weights from nonsmokers were –144.9,  237.8,
 240.5,  247.1 and –252.9g for 1–9, 10–19, 20–29, 30–39 and
40+cpd, respectively). However, no such trend was observed
among the cases (differences from nonsmokers were –209.2,
 222.7,  245.6, +70.5 and –386.1g for 1–9, 10–19, 20–29, 30–39
and 40+cpd, respectively). These results would tend to indicate
inaccurate reporting of smoking by case mothers, but they should
be interpreted with caution, given the maternal source of the birth
weight data. Furthermore, unusual birth weight distributions have
been reported for certain childhood cancers (Yeazel et al, 1997),
which also complicates interpretation.
Participating controls lived in more affluent areas than the
originally selected controls and the cases (Law et al, 2002). This
bias could not explain the observed case–control difference in
reported maternal smoking since the risk should move in the
opposite direction. Since smoking is such a well-known risk factor
for cancer and for unfavourable pregnancy outcomes (e.g. low
birth weight), the possibility of guilt feelings leading to under-
reporting, especially in case mothers, must be considered (Heller
et al, 1998). This is suggested by the smoking prevalence at various
time points (Table 7). Slightly more case than control mothers
reported giving up smoking in pregnancy. In addition, it is known
that some smokers deny having smoked, denial rates varying with
the phrasing of questions and whether medical advice against
smoking had been given (Lee, 1998).
A separate study on reactions of parents before, during and after
interview was independently carried out by sending questionnaires
to a subset of 371 cases and 380 controls as soon as the interview
was completed (Jenkinson et al, 2001). The results lend support to
the proposition that the pattern shown in Table 7 is because of
reporting bias in the case mothers since differential reactions
between case and control mothers were found. Case mothers felt
more difficulty than controls (20 vs 11%, P¼0.02) when
Table 2 Paternal preconception cigarette smoking in relation to childhood cancer risks
Before adjustment After adjustment
a
Diagnostic group Cases Controls OR 95% CI OR 95% CI
All cancer 3585 6987
Lifelong nonsmoker 1543 3082 1.00 1.00
1–19cpd 583 1003 1.16
* 1.03 1.31 1.11 0.98 1.25
20+cpd 757 1440 1.05 0.94 1.17 1.01 0.90 1.12
Trend P 0.198 0.635
Ex-smoker 421 827 1.02 0.89 1.16 1.05 0.92 1.20
Smoking status n/k 281 635
Leukaemia 1630 6987
Lifelong nonsmoker 697 3082 1.00 1.00
1–19cpd 269 1003 1.19
* 1.01 1.39 1.12 0.96 1.32
20+cpd 342 1440 1.07 0.93 1.24 1.01 0.87 1.17
Trend P 0.216 0.743
Ex-smoker 192 827 1.03 0.86 1.23 1.05 0.87 1.25
Smoking status n/k 130 635
Lymphoma 331 6987
Lifelong nonsmoker 124 3082 1.00 1.00
1–19cpd 55 1003 1.34 0.96 1.87 1.27 0.91 1.70
20+cpd 72 1440 1.15 0.85 1.56 1.09 0.80 1.49
Trend P 0.260 0.419
Ex-smoker 45 827 1.32 0.93 1.89 1.43 0.99 2.05
Smoking status n/k 35 635
CNS 635 6987
Lifelong nonsmoker 271 3082 1.00 1.00
1–19cpd 101 1003 1.13 0.89 1.43 1.08 0.85 1.38
20+cpd 138 1440 1.07 0.86 1.33 1.03 0.82 1.28
Trend P 0.466 0.706
Ex-smoker 71 827 0.98 0.74 1.28 1.01 0.76 1.33
Smoking status n/k 54 635
Other solid tumours 989 6987
Lifelong nonsmoker 451 3082 1.00 1.00
1–19cpd 158 1003 1.08 0.89 1.31 1.05 0.86 1.28
20+cpd 205 1440 0.99 0.83 1.18 0.98 0.81 1.17
Trend P 0.981 0.909
Ex-smoker 113 827 0.95 0.76 1.19 1.01 0.81 1.26
Smoking status n/k 62 635
*Po0.05.
aFor deprivation and parental age at birth of index child. cpd=cigarettes per day, n/k=not known.
Parental smoking and childhood cancer
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case and control mothers reported a similar level of difficulty over
questions about employment history (11 vs. 11%, P¼0.91).
Occupations are not generally perceived to be associated with
the risk of childhood cancer (McKinney et al, 2002).
While smoking during pregnancy is well-known to have adverse
effects on the fetus, the possible mutational effects of tobacco
products on germ cells would not generally be understood. It is
unlikely therefore that responses to questions about preconcep-
tional smoking would be influenced in the same way, so these data
are likely to be more reliable.
The only clear positive association to emerge from these
analyses is between maternal preconceptional smoking and
hepatoblastoma. This may be a chance finding arising because of
multiple testing. However, detailed results support the finding, and
potential confounders (deprivation, maternal/paternal ages at
diagnosis of the index child) have not accounted for it. Trends
with numbers of cigarettes smoked approached statistical sig-
nificance (P¼0.058). Smoking by both parents increased the risk
more than four-fold (P¼0.003). Furthermore, maternal smoking
was strongly associated with cases diagnosed above the median
age, suggesting specificity in the timing of a putative carcinogenic
event. Since a chance association would predict a random
distribution among subgroups analysed, the results suggest that
parental smoking might increase the risk of hepatoblastoma.
Alternatively, other unknown risk factors associated with parental
smoking may explain the results. If causal, the most plausible
explanation would be a transplacental carcinogenic effect of
tobacco products, including passive smoking from the father’s
cigarettes affecting the embryonal and/or fetal liver rather than
maternal germ cells. We did not collect information on paternal
smoking during the pregnancy and analyses of reported maternal
smoking during pregnancy do not support this explanation.
However, for reasons mentioned above regarding probable
under-reporting of maternal smoking, preconception smoking
can be used as a proxy for pregnancy smoking.
Tobacco-specific carcinogens can cross the placental barrier to
reach the fetal liver and potentially lead to mutations in oncogenes
or tumour suppressor genes. Fifty-five proven carcinogens have
been found in cigarettes, including polycyclic aromatic hydro-
carbons, N-nitrosamines, aromatic amines, heterocyclic aromatic
amines, aldehydes, aza-arenes, other organic compounds and
Table 3 Maternal preconception cigarette smoking in relation to childhood cancer risks
Before adjustment After adjustment
a
Diagnostic group Cases Controls OR 95% CI OR 95% CI
All cancer 3814 7581
Lifelong nonsmoker 1991 3916 1.00 1.00
1–19cpd 795 1490 1.05 0.95 1.16 1.00 0.90 1.11
20+cpd 394 882 0.88 0.77 1.00 0.86
* 0.75 0.99
Trend P [0.206] [0.072]
Ex-smoker 353 758 0.92 0.80 1.05 0.95 0.83 1.10
Smoking status n/k 281 535
Leukaemia 1723 7581
Lifelong nonsmoker 899 3916 1.00 1.00
1–19cpd 351 1490 1.04 0.90 1.19 0.99 0.86 1.15
20+cpd 191 882 0.96 0.81 1.14 0.96 0.80 1.16
Trend P [0.864] [0.652]
Ex-smoker 153 758 0.86 0.71 1.04 0.88 0.73 1.07
Smoking status n/k 129 535
Lymphoma 351 7581
Lifelong nonsmoker 180 3916 1.00 1.00
1–19cpd 67 1490 0.95 0.71 1.27 0.87 0.63 1.18
20+cpd 38 882 0.93 0.65 1.34 0.86 0.58 1.27
Trend P [0.624] [0.274]
Ex-smoker 39 758 1.15 0.80 1.65 1.25 0.86 1.80
Smoking status n/k 27 535
CNS 684 7581
Lifelong nonsmoker 349 3916 1.00 1.00
1–19cpd 143 1490 1.06 0.86 1.30 1.00 0.80 1.24
20+cpd 67 882 0.84 0.64 1.10 0.78 0.58 1.05
Trend P [0.385] [0.157]
Ex-smoker 67 758 1.01 0.77 1.33 1.05 0.79 1.39
Smoking status n/k 58 535
Other solid tumours 1056 7581
Lifelong nonsmoker 563 3916 1.00 1.00
1–19cpd 234 1490 1.09 0.93 1.29 1.05 0.88 1.25
20+cpd 98 882 0.77
* 0.61 0.96 0.75
* 0.58 0.96
Trend P [0.144] [0.111]
Ex-smoker 94 758 0.86 0.68 1.09 0.92 0.73 1.16
Smoking status n/k 67 535
aFor deprivation and parental age at the birth of the index child.
*Po0.05. cpd=cigarettes per day. [ ] indicates negative trend, n/k=not known.
Parental smoking and childhood cancer
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Before adjustment After adjustment
a
Diagnostic group Cases Controls OR 95% CI OR 95% CI
All cancer
Nonsmoker 2958 5743 1.00 1.00
1–19cpd 648 1306 0.96 0.87 1.06 0.92 0.82 1.03
20+cpd 207 528 0.76
** 0.64 0.90 0.71
*** 0.59 0.85
Trend P [0.004] [o0.001]
Leukaemia
Nonsmoker 1341 5743 1.00 1.00
1–19cpd 286 1306 0.95 0.83 1.10 0.93 0.80 1.08
20+cpd 95 528 0.80 0.64 1.01 0.76
* 0.60 0.98
Trend P [0.069] [0.029]
Lymphoma
Nonsmoker 269 5743 1.00 1.00
1–19cpd 60 1306 0.99 0.74 1.32 0.92 0.67 1.26
20+cpd 22 528 0.82 0.52 1.29 0.72 0.44 1.20
Trend P [0.481] [0.208]
CNS
Nonsmoker 538 5743 1.00 1.00
1–19cpd 111 1306 0.89 0.72 1.11 0.86 0.68 1.08
20+cpd 35 528 0.69
* 0.48 0.98 0.62
* 0.42 0.93
Trend P [0.029] [0.011]
Other solid tumours
Nonsmoker 810 5743 1.00 1.00
1–19cpd 191 1306 1.02 0.86 1.21 0.94 0.78 1.13
20+cpd 55 528 0.73
* 0.55 0.97 0.68
* 0.49 0.93
Trend P [0.123] [0.030]
aFor parental age and deprivation.
*Po0.05;
**Po0.01;
***Po0.001. cpd=cigarettes per day. [ ] indicates negative trend.
Table 5 Parental smoking in relation to childhood cancer risks by selected diagnostic subgroups
Father preconception Mother preconception Mother pregnancy
Diagnostic group
a Cases
b OR
d 95% Cl Cases
c OR
d 95% Cl Cases
c OR
d 95% Cl
110 Acute lymphocytic leukaemia 1375 1.04 0.91 1.18 1449 1.02 0.89 1.16 1449 0.89 0.77 1.03
120 Acute myeloid leukaemia 230 1.07 0.80 1.43 249 0.82 0.60 1.12 249 0.76 0.54 1.07
130 Chronic myeloid leukaemia 22 1.44 0.59 3.50 22 1.44 0.57 3.65 22 1.70 0.68 4.26
210 Hodgkin’s disease 105 1.16 0.75 1.70 114 0.75 0.47 1.19 114 0.91 0.57 1.45
220 Non-Hodgkin’s lymphoma 218 1.03 0.76 1.40 229 0.90 0.65 1.23 229 0.86 0.61 1.22
311 Pilocytic astrocytoma 158 1.08 0.76 1.52 169 0.89 0.62 1.28 169 0.92 0.62 1.37
315 Other astrocytoma 119 0.92 0.61 1.39 132 0.94 0.62 1.43 132 0.84 0.53 1.33
320 Other glioma 66 1.09 0.64 1.84 67 0.97 0.55 1.71 67 1.12 0.63 1.99
330 Ependymoma 61 1.03 0.59 1.78 69 0.73 0.40 1.35 69 0.77 0.40 1.47
340 Choroid plexus tumours 20 2.11 0.81 5.49 20 1.29 0.44 3.79 20 0.49 0.14 1.75
350 Primitive neuroectodermal tumours 150 0.90 0.63 1.30 161 0.96 0.65 1.42 161 0.55
* 0.34 0.88
360 Mis. brain and spinal neoplasms 61 1.33 0.77 2.28 66 0.82 0.46 1.45 66 0.74 0.39 1.40
400 Retinoblastoma 86 0.66 0.40 1.09 87 0.60 0.40 1.10 87 0.60 0.30 1.10
510 Neuroblastoma 180 1.35 0.97 1.88 188 1.04 0.73 1.49 188 0.91 0.62 1.34
520 Peripheral neuroectodermal tumours 74 1.12 0.68 1.80 78 1.52 0.93 2.48 78 1.48 0.88 2.47
610 Wilms’ tumour 170 1.01 0.73 1.42 182 0.82 0.57 1.17 182 0.82 0.55 1.22
630 Other and unspecified renal tumours 10 1.76 0.37 8.31 12 0.98 0.26 3.71 12 0.98 0.24 3.99
710 Hepatoblastoma 27 2.19 0.94 5.12 28 2.68
* 1.16 6.21 28 1.10 0.44 2.72
810 Osteosarcoma 48 1.18 0.65 2.14 56 1.06 0.56 2.01 56 0.46 0.20 1.06
830 Rhabdomyosarcoma 125 0.84 0.57 1.25 132 0.83 0.55 1.25 132 1.02 0.66 1.56
850 Other soft tissue sarcoma 62 0.81 0.46 1.43 69 1.02 0.57 1.80 69 0.98 0.53 1.83
910 Gonadal germ cell tumours 34 0.98 0.47 2.03 35 0.82 0.37 1.84 35 0.70 0.28 1.75
920 Nongonadal germ cell tumours 57 0.81 0.46 1.46 61 0.74 0.41 1.37 61 0.53 0.25 1.10
1000 Rare miscellaneous tumours 51 1.14 0.62 2.08 57 1.21 0.66 2.22 57 1.16 0.62 2.18
1200 Langerhans cell histiocytosis 46 0.73 0.38 1.40 49 0.74 0.37 1.48 49 0.47 0.20 1.15
aBirch–Kelsey classification (UKCCS Investigators, 2000), excluding diagnostic subgroups with less than 10 cases.
bCorresponding controls: 6987.
cCorresponding controls: 7581.
dAfter adjustment for parental age and deprivation.
*Po0.05.
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yinorganic compounds (Hecht, 1999). Of these, N-nitroso com-
pounds are the most likely candidate transplacental liver carcino-
gens (Anderson et al, 1989; Correa et al, 1990; Beebe et al, 1993;
Schuller et al, 1993, 1994; Hecht, 1998). These compounds can
cross the human placenta, and their metabolites have been found
both in the urine and bound to the fetal haemoglobin of newborns
whose mothers smoked cigarettes (Coghlin et al, 1991; Lackmann
et al, 1999) and in the fetus in early pregnancy (Milunsky et al,
2000). Cord blood T lymphocytes from newborns has revealed an
increased level of mutations (deletions in infants of mothers who
smoked (Finette et al, 1997)). The liver is a target organ for
transplacental carcinogenesis in experimental animals and, indeed,
the enzymes necessary for their bioactivation are more active in
human than in animal fetal liver (Everson, 1980).
For adults, carcinogens in cigarettes mainly target the first
exposed organ, the lung, (Hecht, 1999), but in the fetus, the first
exposed organ may be the liver, so a role for parental smoking
during pregnancy may be biologically plausible in childhood
hepatoblastoma. However, although a causal association with
hepatoblastoma should be considered, given the number of
comparisons made the apparent association could well be due to
chance.
In conclusion, no statistically significant positive associations
between parental smoking behaviour and major groups of cancers
in children were identified by the UKCCS. However, causal
associations cannot be ruled out. If there is under-reporting of
smoking in the case parents, the true effects would be expected to
be higher than observed in the present study. To resolve this
question, new approaches are required and the integration of
biomarkers for genotypes and phenotypes specific to tobacco
products would be helpful in pursuing the possible role of parental
smoking in the aetiology of childhood cancer.
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Table 7 Prevalence (%) of maternal cigarette smoking in cases and
controls
Time point
Preconception 1st trimester 2nd trimester 3rd trimester
Cases 33.7 25.7 22.4 22.4
Controls 33.7 26.9 24.2 23.9
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